Table 1 .

Clinical characteristics from the ductal carcinoma samples.

Sample Name	Stage	Age	TNM	LN	Grade	Molecular Markers
9T	IIa	55 years	T2N0M0	Negative	Grade I SBR	ER +/ PR +/ p53 -/ ERBB2+ (3+)
20T	IIb	87 years	T2N0M0	Negative	Grade II SBR	ER +/ PR -/ p53 -/ ERBB2+ (3+)
22T	IIb	56 years	T2N1M0	Positive	Grade III SBR	ER +/ PR -/ p53 -/ ERBB2+ (2+/3+)
28T	IIIa	42 years	T2N2M0	Positive	Grade II SBR	ER +/ PR -/ p53 -/ ERBB2+ (3+)
36T	I	45 years	T1N0M0	Negative	Grade III SBR	ER +/ PR -/ p53 -/ ERBB2+ (3+)

Age: age of diagnosis; TNM: classification according to TNM (T – size; N – lymph node status; M – presence of metastasis); LN: involvement of sentinel lymph nodes; grade: grades I, II and III according to SBR; molecular markers: ER – estrogen receptor; PR – progesterone receptor; p53 – protein TP53; and ERBB2 – protein ERBB2.